Chronic active hepatitis with cholestatic features. I. A clinical and immunological study

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Chronic active hepatitis (CAH) is a significant liver disease.
• A subset of CAH patients exhibits cholestatic features, impacting disease prognosis.
• Understanding these features is crucial for patient management and predicting outcomes.

Purpose of the Study:

• To identify and characterize patients with chronic active hepatitis (CAH) presenting with cholestatic features.
• To compare the clinical, laboratory, and epidemiological characteristics of CAH patients with and without cholestasis.
• To evaluate the impact of cholestatic features on disease severity, treatment response, and mortality in CAH.

Main Methods:

• Retrospective analysis of 43 chronic active hepatitis (CAH) patients.
• Selection criteria for cholestatic group: pruritus, elevated alkaline phosphatase, and high cholesterol levels.
• Comparison of clinical, laboratory, and epidemiological data between cholestatic CAH patients and controls.

Main Results:

• 28% of CAH patients exhibited cholestatic features.
• Cholestatic CAH patients showed a higher prevalence of Ashkenazi Jews of Roumanian origin, joint/thyroid involvement, and elevated serum Ig-M levels.
• Despite similar overall mortality, cholestatic CAH patients tended to die earlier, had less frequent remissions, and developed cirrhosis more readily.

Conclusions:

• Chronic active hepatitis (CAH) with cholestatic features represents a more aggressive form of the disease.
• Cholestatic CAH is associated with poorer treatment outcomes, including reduced remission rates and increased cirrhosis development.
• These findings highlight the need for closer monitoring and potentially tailored treatment strategies for CAH patients with cholestatic manifestations.